SNMMI

After radiosurgery concurrent with nivolumab in 59-year-old patient with melanoma BM (patient 1; Supplemental Tables 3 and 5), F-18 FET PET at follow-up 12 weeks after treatment initiation (bottom row) shows significant decrease of metabolic activity (TBRmean, ?28%) compared with baseline (top row), although MRI changes were consistent with progression according to iRANO criteria. Reduction of metabolic activity was associated with stable clinical course over 10 mo. CE = contrast-enhanced. Image created by

PET Imaging Adds Valuable Information to Brain Metastasis Monitoring

May 5, 2021 — For patients with brain metastases, amino acid positron emission tomography (PET) can provide valuable ...

May 05, 2021

#NorthStar Medical #Radioisotopes, LLC, a global innovator in the development, production and commercialization of #radiopharmaceuticals used for #medicalimaging and #therapeutic applications, announced a corporate update highlighting progress across its key programs during the past twelve months and upcoming milestones.

News | Radiopharmaceuticals and Tracers

NorthStar Medical Radioisotopes Provides Updates on Corporate Progress

April 16, 2021 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

April 16, 2021

CXCR4-directed PET correlates with MRI-determined lymphoma lesions. Depicted are representative MR images (T1c- and FLAIR- sequences), and the corresponding CXCR4- directed PET images and fusion images (MRI-FLAIR and PET), of two patients with PCNSL and SCNSL, respectively. Images created by Department of Nuclear Medicine, School of Medicine, Technische Universität München, Munich, Germany.

News | PET Imaging

PET Imaging Tracer Effective for Diagnosing and Managing Rare CNS B-cell Lymphoma

December 14, 2020 — Positron emission tomography (PET) imaging with 68Ga-pentixafor is an effective diagnostic tool for ...

December 14, 2020

News | Nuclear Imaging

The Journal of Nuclear Medicine Celebrates 60 Years of Research

December 14, 2020 — The Journal of Nuclear Medicine (JNM) has issued a special supplement commemorating six decades of ...

December 14, 2020

Tau (blue) and amyloid (orange) distribution patterns for super-agers, normal-agers and MCI patients, when compared to a group of younger, healthy, cognitively normal, amyloid-negative individuals. Brain projections are depicted at an uncorrected significance level of p < .0001. Color bars represent the respective t-statistic. Image courtesy of Merle C. Hoenig, Institute for Neuroscience and Medicine II - Molecular Organization of the Brain, Research Center Juelich, Juelich, Germany, and Department of Nucle

News | PET Imaging

SNMMI Image of the Year Features Super-agers

July 16, 2020 — Super-agers, or individuals whose cognitive skills are above the norm even at an advanced age, have been ...

July 16, 2020

Novel imaging agent provides foundation to inform treatment strategies

News | PET Imaging

Molecular Imaging Identifies Link Between Heart and Kidney Inflammation After Heart Attack

July 16, 2020 — Whole body positron emission tomography (PET) has, for the first time, illustrated the existence of ...

July 16, 2020

PSMA PET/CT accurately detects recurrent prostate cancer in 67-year-old man. 18F-DCFPyL-PSMA PET/CT shows extensive, intensely PSMA-avid local recurrence in prostate (bottom row; solid arrow) in keeping with the known tumor recurrence in the prostate. Right: PET shows extensive, intensely PSMA-avid local recurrence in prostate (top row; solid arrow) and a solitary bone metastasis in left rib 2 (bottom row; dotted arrow). Image courtesy of Ur Metser, et al.

News | PET-CT

PSMA PET/CT Can Change Management in Recurrent Prostate Cancer

July 16, 2020 — New research confirms the high impact of PSMA PET/CT in the detection and management of recurrent ...

July 16, 2020

Total-body dynamic 18F-FDG PET imaging with the uEXPLORER scanner allows us to monitor the spatiotemporal distribution of glucose concentration in metastatic tumors in the entire body (a). As compared to a typical clinical standardized uptake value image (b), the parametric image of FDG influx rate (Ki) can achieve higher lesion-to-background (e.g., the liver) contrast. In addition to glucose metabolism imaging by Ki, total-body dynamic PET also enables multiparametric characterization of tumors and organs

News | PET Imaging

Total-body Dynamic PET Successfully Detects Metastatic Cancer

July 16, 2020 — Results from the first study using uEXPLORER to conduct total-body dynamic positron emission tomography ...

July 16, 2020

PET/CT imaging showing uptake and retention of 86Y-NM600 (imaging agent) in immunocompetent mice bearing prostate tumors. PET imaging data was employed to estimate tumor dosimetry and prescribe an immunomodulatory 90Y-NM600 (therapy agent) injected activity. Image courtesy of R Hernandez et al., University of Wisconsin-Madison, WI.

News | PET-CT

Targeted Radionuclide Therapy Enhances Prostate Cancer Response to Immunotherapies

July 15, 2020 — Targeted radionuclide therapy has been found to create a favorable tumor microenvironment in prostate ...

July 15, 2020

Adult male with decades of right neck pain, discomfort and tightening following birth injury. The patient had failed multiple standard therapeutic maneuvers before presenting for 18F-FDG PET/MR imaging. Images shows abnormally elevated FDG uptake (white arrows; SUVmax = 1.2) observed in a linear pattern in the space in the posterolateral right neck, between the oblique capitis inferior and the semispinalis capitis muscles, where the greater occipital nerve resides. By comparison, the same region on the cont

News | SNMMI

New PET/MRI Approach Pinpoints Chronic Pain Location, Alters Management

July 14, 2020 — A new molecular imaging approach utilizing 18F-FDG positron emission tomography (PET) and magnetic ...

July 14, 2020

Left: Total-body PET/CT in psoriatic arthritis: multiple joints affected, shoulders, elbows, wrists, knees, ankles and small joints of the hands/feet. Arrow: left wrist; arrowhead: right wrist. Middle: Total-body PET/CT in rheumatoid arthritis: multiple joints affected, right shoulder, small joints of the left hand. Arrowhead at the 4th proximal interphalangeal joint shows classic ring-like uptake pattern. Arrow on the foot images demonstrates the hammer toe deformity besides big toe arthritis. Right: Total

News | SNMMI

Total-body PET/CT Captures Full Picture of Systemic Inflammatory Arthritis

July 14, 2020 — For the first time, physicians can examine the systemic burden of inflammatory arthritis simultaneously ...

July 14, 2020

Maximum-intensity projections, transaxial fusion, and PET images of 18F-PSMA1007 (A-C) and 68Ga-PSMA-11 (D-F) PET/CT scans of 67-y-old patient with GS 8 and PSA 4.9 ng/mL. Marked uptake is seen in urinary bladder and left ureter (arrow) on maximum-intensity projection image of 68Ga-PSMA-11 (D), as opposed to nearly negligible 18F-PSMA-1007 urinary excretion (A). Dominant lesion in left prostatic lobe is evident on both scans (arrowheads). However, second lesion is seen in right lobe only on 18F-PSMA-1007 sc

News | Prostate Cancer

Novel Radiotracer Meets Gold Standard for Imaging Prostate Cancer

May 12, 2020 — The novel radiopharmaceutical 18F-PSMA-1007 is both effective and readily available for detecting ...

May 12, 2020

The Society of Nuclear Medicine and Molecular Imaging's 2020 annual meeting has been reimagined, and is now the SNMMI 2020 Annual Meeting — Virtual Edition

News | Coronavirus (COVID-19)

SNMMI the Latest Event to Turn Virtual

April 30, 2020 — The Society of Nuclear Medicine and Molecular Imaging's 2020 annual meeting has been reimagined, and is ...

April 30, 2020

Maximum-intensity PET projections at each time point for one rhesus monkey in the 89Zr-DFO-squaramide-anti-gD group.

News | PET Imaging

Total-body PET Imaging Successfully Identifies Antibodies up to 30 Days After Injection

April 10, 2020 — Combining 89Zr-labeled antibodies with total-body positron emission tomography (PET) has extended the ...

April 10, 2020

Recommended best practices for nuclear imaging departments under the COVIF-19 pandemic have been issues by the ASNC and SNMMI. #COVID19 #ASNC #SNMMI #Coronavirus #SARScov2

News | Coronavirus (COVID-19)

Best Practices for Nuclear Imaging During the Coronavirus (COVID-19) Pandemic

April 3, 2020 — A new guidance document on best practices to maintain safety and minimize contamination in nuclear ...

April 03, 2020

#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

News | Coronavirus (COVID-19)

SNMMI Launches COVID-19 Resource Center

March 31, 2020 — In a letter to its members, Society of Nuclear Medicine and Molecular Imaging (SNMMI) President Vasken ...

March 31, 2020

News | Radiation Therapy

ASTRO and ACR Update Practice Parameters for Radiation Therapy Treatments

October 22, 2019 — The American Society for Radiation Oncology (ASTRO) and the American College of Radiology (ACR) ...

October 22, 2019

Technology | Information Technology

DOSIsoft Receives FDA 510(k) Clearance for Planet Onco Dose Software

June 20, 2019 — DOSIsoft announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to ...

June 20, 2019

Technology | Nuclear Imaging

MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry

January 16, 2019 — MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for ...

January 16, 2019

Technology | Nuclear Imaging

Siemens Healthineers Announces FDA Clearance of syngo.via VB30 Molecular Imaging Software

July 16, 2018 — At the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26 ...

July 16, 2018